Michael Steinberg

Michael Lee Steinberg

Department Chair, Radiation Oncology, University of California Los Angeles

Professor Of Clinical, Radiation Oncology, University of California Los Angeles

310-825-9771

200 UCLA Medical Plaza
Ste B265
BOX 956951
Los Angeles, CA 90095

Fax Number:
310-794-9795

Office Phone Number:
310-825-9775

Work Phone Number:
(310) 828-0061

UC Profile

Affiliations

Member, CTSI, JCCC Genitourinary Oncology Program Area, JCCC Healthy and At-Risk Populations Program Area, Physics & Biology in Medicine GPB Home Area

Biography

Dr. Steinberg is Professor and Chair of the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA. His professional career spans private, corporate and academic practice and is known for the development of multi-site radiation oncology care networks that are characterized by clinical excellence and community based clinical research. The UCLA Radiation Oncology network includes the department at Ronald Reagan Medical Center at UCLA, academically oriented community practices as well as Children’s Hospital Los Angeles. Dr. Steinberg has specific expertise in the treatment of tumors of the GU system, breast and head and neck. He specializes in the use of technically advanced treatment modalities such as Stereotactic Body Radiation Therapy (SBRT) and brachytherapy for the treatment of malignancy. Dr. Steinberg publishes and is a speaker on issues related to health policy including quality of care, technology assessment, healthcare economics and disparity. He served as the PI for a National Cancer Institute Cancer Disparity Research grant and as a health services research investigator and manuscript author at the RAND Corporation. Dr. Steinberg has been influential in providing input regarding health policy and economic issues on behalf of patients and his specialty through his various leadership roles in radiation oncology. He is the founding Chair of the Health Policy Council of American Society of Radiation Oncology (ASTRO) and served as a member of the board of that organization. Dr. Steinberg is the radiation oncology representative to the American Medical Association’s CPT Editorial Panel, served two terms on the Medicare Evidence and Coverage Advisory Committee (MCAC) and chairs of the Health Policy Committee of the Commission on Radiation Oncology of the American College of Radiology. He also currently serves on the Carrier Advisory Committee (CAC) for his regional Medicare carrier. Dr. Steinberg graduated Occidental College Phi Beta Kappa, was elected to AOA at University of Southern California School of Medicine and did his radiation oncology residency and fellowship at UCLA.

Publications

  1. Nikitas J, Ballas LK, Romero T, Lynch C, Ma TM, Valle LF, Sachdeva A, Chong N, Basehart V, Franco A, Reiter R, Saigal C, Chamie K, Litwin MS, Donin NM, Rettig M, Nickols NG, Cao M, Liauw SL, Steinberg ML, Kishan AU. Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical Trial.. JAMA oncology, 2025.
  2. Kishan AU, McGreevy K, Valle L, Steinberg M, Neilsen B, Casado M, Cao M, Telesca D, Weidhaas JB. Validation and Derivation of MicroRNA-based Germline Signatures Predicting Radiation Toxicity in Prostate Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research, 2025.
  3. Kishan AU, Sun Y, Tree AC, Hall E, Dearnaley D, Catton CN, Lukka HR, Pond G, Lee WR, Sandler HM, Feng FY, Nguyen PL, Incrocci L, Heemsbergen W, Pos FJ, Horwitz E, Wong JK, Hoffman KE, Hassanzadeh C, Kuban DA, Arcangeli S, Sanguineti G, Supiot S, Crehange G, Latorzeff I, Kalbasi TR, Steinberg ML, Valle LF, Loblaw A, Nikitas J, Roy S, Zaorsky NG, Jia AY, Spratt DE. Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium.. The Lancet. Oncology, 2025.
  4. Courtney PT, Venkat PS, Shih YT, Chang AJ, Lee A, Steinberg ML, Raldow AC. Cost-Effectiveness of Pembrolizumab With Chemoradiotherapy for Locally Advanced Cervical Cancer.. JAMA network open, 2025.
  5. Nikitas J, Jamshidian P, Tree AC, Hall E, Dearnaley D, Michalski JM, Lee WR, Nguyen PL, Sandler HM, Catton CN, Lukka HR, Incrocci L, Heemsbergen W, Pos FJ, Roy S, Malone S, Horwitz E, Wong JK, Arcangeli S, Sanguineti G, Romero T, Sun Y, Steinberg ML, Valle LF, Weidhaas JB, Spratt D, Telesca D, Kishan AU. The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials.. The Lancet. Oncology, 2025.
  6. Valle LF, Chu FI, Wang X, Erman A, Hernandez J, Kaoh E, Edgar N, Raldow AC, Wong DJ, Steinberg ML, Kishan AU, Chin RK, Hegde JV. Patient-reported quality of life and adherence outcomes after integrating exclusive liquid meal replacement in patients with head and neck cancer undergoing chemoradiation: results from a phase II study.. Frontiers in oncology, 2025.
  7. Murthy V, Mallick I, Maitre P, Mulye G, Arunsingh M, Valle L, Steinberg M, Kennedy T, Loblaw A, Kishan AU. Pelvic Regional Control With 25 Gy in 5 Fractions in Stereotactic Radiation Therapy for High-Risk Prostate Cancer: Pooled Prospective Outcomes From the SHARP Consortium.. International journal of radiation oncology, biology, physics, 2025.
  8. Wallner PE, Steinberg ML. Time to Slash SABR From Our Lexicon.. Practical radiation oncology, 2024.
  9. Kishan AU, Lamb JM, Wilhalme H, Casado M, Chong N, Zello L, Juarez JE, Jiang T, Neilsen BK, Low DA, Yang Y, Neylon J, Basehart V, Martin Ma T, Valle LF, Cao M, Steinberg ML. Magnetic Resonance Imaging Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy in Prostate Cancer: 2-year Outcomes from the MIRAGE Randomized Clinical Trial.. European urology, 2024.
  10. Armstrong WR, Kishan AU, Booker KM, Grogan TR, Elashoff D, Lam EC, Clark KJ, Steinberg ML, Fendler WP, Hope TA, Nickols NG, Czernin J, Calais J. Corrigendum to "Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)" [Eur Urol. 86(1) (2024) 52-60].. European urology, 2024.
  11. Nikitas J, Castellanos Rieger A, Farolfi A, Seyedroudbari A, Kishan AU, Nickols NG, Steinberg ML, Valle LF, Rettig M, Czernin J, Calais J. Prostate-Specific Membrane Antigen PET/CT-Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024.
  12. Nikitas J, Lam E, Booker KA, Fendler WP, Eiber M, Hadaschik B, Herrmann K, Hirmas N, Lanzafame H, Stuschke M, Czernin J, Steinberg ML, Nickols NG, Kishan AU, Calais J. Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial).. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024.
  13. Nikitas J, Subramanian K, Gozal NB, Ricaurte-Fajardo A, Li E, Proudfoot JA, Davicioni E, Marciscano AE, Osborne JR, Barbieri CE, Armstrong WR, Smith CP, Valle LF, Steinberg ML, Boutros PC, Nickols NG, Rettig MB, Reiter R, Weiner AB, Calais J, Czernin J, Ross AE, Kim EH, Nagar H, Kishan AU. Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study.. JCO precision oncology, 2024.
  14. Wallner PE, Steinberg ML, Burmeister J, Curran WJ, Das P, Davis BJ, Haffty BG, Marples B, Zietman AL. Why Basic Science Education Matters in Radiation Oncology.. American journal of clinical oncology, 2024.
  15. Gao Y, Yoon S, Ma TM, Yang Y, Sheng K, Low DA, Ballas L, Steinberg ML, Kishan AU, Cao M. Intra-fractional geometric and dose/volume metric variations of magnetic resonance imaging-guided stereotactic radiotherapy of prostate bed after radical prostatectomy.. Physics and imaging in radiation oncology, 2024.
  16. Nikitas J, Rettig M, Shen J, Reiter R, Lee A, Steinberg ML, Valle LF, Sachdeva A, Romero T, Calais J, Czernin J, Nickols NG, Kishan AU. Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial.. European urology, 2024.
  17. Nikitas J, Kishan A, Chang A, Duriseti S, Nichols NG, Reiter R, Rettig M, Brisbane W, Steinberg ML, Valle L. Treatment intensification strategies for men undergoing definitive radiotherapy for high-risk prostate cancer.. World journal of urology, 2024.
  18. Nickols NG, Tsai S, Kane N, Tran S, Ghayouri L, Diaz-Perez S, Thein M, Anderson-Berman N, Eason J, Kishan AU, Steinberg ML, Reiter RE, Lee SP, Gin GE, Kwon R, Chang MG, Chao HH, Solanki AA, Sexton R, Lewis M, Lorentz W, Cheung MK, Gage DL, Duriseti S, Valle L, Berenji G, Aronson WJ, Garraway IP, Rettig MB. Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer.. European urology, 2024.
  19. Luximon DC, Neylon J, Ritter T, Agazaryan N, Hegde JV, Steinberg ML, Low DA, Lamb JM. Results of an Artificial Intelligence-Based Image Review System to Detect Patient Misalignment Errors in a Multi-institutional Database of Cone Beam Computed Tomography-Guided Radiation Therapy.. International journal of radiation oncology, biology, physics, 2024.
  20. Wu TC, Luterstein E, Neilsen BK, Goldman JW, Garon EB, Lee JM, Felix C, Cao M, Tenn SE, Low DA, Kupelian PA, Steinberg ML, Lee P. Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.. JAMA oncology, 2024.
  21. Wallner PE, Knisely JPS, Phillips TL, Roach M, Sahgal A, Steinberg ML. In Memoriam: David A. Larson, MD, PhD, FASTRO (December 17, 1940 - November 4, 2022).. International journal of radiation oncology, biology, physics, 2024.
  22. Armstrong WR, Kishan AU, Booker KM, Grogan TR, Elashoff D, Lam EC, Clark KJ, Steinberg ML, Fendler WP, Hope TA, Nickols NG, Czernin J, Calais J. Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774).. European urology, 2024.
  23. Courtney PT, Valle LF, Raldow AC, Steinberg ML. MRI-Guided Radiation Therapy-An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations.. Seminars in radiation oncology, 2024.
  24. Neylon J, Ma TM, Savjani R, Low DA, Steinberg ML, Lamb JM, Nickols NG, Kishan AU, Cao M. Quantifying Intrafraction Motion and the Impact of Gating for Magnetic Resonance Imaging-Guided Stereotactic Radiation therapy for Prostate Cancer: Analysis of the Magnetic Resonance Imaging Arm From the MIRAGE Phase 3 Randomized Trial.. International journal of radiation oncology, biology, physics, 2023.
  25. Nikitas J, Ong WL, Carrier N, Romero T, Millar J, Steinberg ML, Rettig MB, Boutros PC, Reiter R, Nickols NG, Valle L, McGuire SE, Spratt DE, Souhami L, Roy S, Martin JM, Joseph D, Nabid A, Kishan AU. Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials.. International journal of radiation oncology, biology, physics, 2023.
  26. Coleman CN, Wong R, Petereit DG, Maguire PD, Heron DE, Steinberg M, Bains Y, Vikram B, Angelis P, Livinski AA, Roach M, Govern FS. The National Cancer Institute's Cancer Disparities Research Partnership Program: a unique funding model 20 years later.. Journal of the National Cancer Institute, 2023.
  27. Ma TM, Agarwal N, Mahal B, Barragan-Carrillo R, Spratt D, Rettig MB, Valle LF, Steinberg ML, Garraway I, Vapiwala N, Xiang M, Kishan AU. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.. JAMA network open, 2023.
  28. Neilsen BK, Ma TM, Akingbemi WO, Neylon J, Casado MC, Sharma S, Sheng K, Ruan D, Low DA, Yang Y, Valle LF, Steinberg ML, Lamb JM, Cao M, Kishan AU. Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate Stereotactic Body Radiation Therapy in a Phase 3 Randomized Trial.. International journal of radiation oncology, biology, physics, 2023.
  29. Chaballout BH, Chang EM, Shaverdian N, Lee PP, Beron PJ, Steinberg ML, Raldow AC. The Patient's perspective on radiation therapy for anal cancer: Evaluation of expectations and stigma.. Cancer reports (Hoboken, N.J.), 2023.
  30. Ong WL, Nikitas J, Joseph D, Steigler A, Millar J, Valle L, Steinberg ML, Ma TM, Reiter RE, Rettig MB, Nickols NG, Chang A, Zaorsky NG, Spratt DE, Romero T, Kishan AU. Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR.. International journal of radiation oncology, biology, physics, 2023.
  31. Chaballout BH, Chang EM, Shaverdian N, Lee PP, Beron PJ, Steinberg ML, Raldow AC. The patient's perspective on radiation for rectal cancer: Initial expectations versus actual experience.. Cancer medicine, 2023.
  32. Benitez CM, Steinberg ML, Cao M, Qi XS, Lamb JM, Kishan AU, Valle LF. MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation.. Cancers, 2023.
  33. Valle LF, Kishan AU, Franco A, Ma TM, Nikitas J, Farrell M, Chang AJ, Nickols NG, Steinberg ML. Selecting the optimal radiation modality in prostate cancer.. Clinical advances in hematology & oncology : H&O, 2023.
  34. Roy S, Romero T, Michalski JM, Feng FY, Efstathiou JA, Lawton CAF, Bolla M, Maingon P, de Reijke T, Joseph D, Ong WL, Sydes MR, Dearnaley DP, Tree AC, Carrier N, Nabid A, Souhami L, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Reiter RE, Rettig MB, Nickols NG, Steinberg ML, Valle LF, Ma TM, Farrell MJ, Neilsen BK, Juarez JE, Deng J, Vangala S, Avril N, Jia AY, Zaorsky NG, Sun Y, Spratt D, Kishan AU, Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators. Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023.
  35. Wu TC, No HJ, Rahimy E, Kishan AU, Steinberg ML, Raldow AC, Beadle BM. Performance Analysis of a Radiation Oncology Educational Podcast.. Journal of the American College of Radiology : JACR, 2023.
  36. Wallner PE, Jimenez RB, Davis BJ, Steinberg ML. Proton Beam Therapy Training, Experience, and Assessment: Ready for Prime Time.. Practical radiation oncology, 2023.
  37. Ma TM, Wong DJ, Chai-Ho W, Mendelsohn A, St John M, Abemayor E, Chhetri D, Sajed D, Dang A, Chu FI, Xiang M, Savjanji R, Weidhaas J, Steinberg ML, Cao M, Kishan AU, Chin RK. High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial.. International journal of radiation oncology, biology, physics, 2023.
  38. Wu TC, Stube A, Felix C, Oseguera D, Romero T, Goldman J, Garon EB, Lee JM, Glaspy J, Lisberg AE, Rusthoven CG, Camidge DR, Siva S, Solomon B, Lee A, Tenn SE, Shaverdian N, Steinberg ML, Raldow AC, Lee P. Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer.. International journal of radiation oncology, biology, physics, 2023.
  39. Mariados NF, Orio PF, Schiffman Z, Van TJ, Engelman A, Nurani R, Kurtzman SM, Lopez E, Chao M, Boike TP, Martinez AA, Gejerman G, Lederer J, Sylvester JE, Bell G, Rivera D, Shore N, Miller K, Sinayuk B, Steinberg ML, Low DA, Kishan AU, King MT. Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial.. JAMA oncology, 2023.
  40. Wallner PE, Steinberg ML. Radiation Oncologists and Therapeutic Radiopharmaceuticals: Will History Repeat Itself?. International journal of radiation oncology, biology, physics, 2023.
  41. Nikitas J, Smith LM, Gao Y, Ma TM, Sachdeva A, Yoon SM, Jiang T, Low DA, Ballas LK, Steinberg ML, Cao M, Kishan AU. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2023.
  42. Raldow AC, Siker ML, Bonner JA, Chen Y, Liu FF, Metz JM, Movsas B, Potters L, Schultz CJ, Wilson E, Wang X, Romero T, Steinberg ML, Jagsi R. Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United States.. Advances in radiation oncology, 2023.
  43. Ma TM, Czernin J, Felix C, Alano R, Wilhalme H, Valle L, Steinberg ML, Dahlbom M, Reiter RE, Rettig MB, Cao M, Calais J, Kishan AU. LUNAR: a randomized Phase 2 study of 177 Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol).. BJU international, 2023.
  44. Kishan AU, Ma TM, Lamb JM, Casado M, Wilhalme H, Low DA, Sheng K, Sharma S, Nickols NG, Pham J, Yang Y, Gao Y, Neylon J, Basehart V, Cao M, Steinberg ML. Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial.. JAMA oncology, 2023.
  45. Smith CP, Xiang M, Armstrong WR, Nickols NG, Steinberg ML, Reiter RE, Rettig M, Weiner AB, Shen J, Valle L, Czernin J, Calais J, Kishan AU. Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials.. International journal of radiation oncology, biology, physics, 2023.
  46. Kishan AU, Marco N, Ma TM, Steinberg ML, Sachdeva A, Cao M, Ballas LK, Rietdorf E, Telesca D, Weidhaas JB. Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial.. Clinical and translational radiation oncology, 2023.
  47. Valle LF, Jiang T, Weiner AB, Reiter RE, Rettig MB, Shen J, Chang AJ, Nickols NG, Steinberg ML, Kishan AU. Multimodality Therapies for Localized Prostate Cancer.. Current oncology reports, 2023.
  48. Nikitas J, Cao M, Nickols NG, Valle L, Steinberg ML, Kishan AU. Early Safety and Efficacy Profile of Homogeneously Dosed Salvage Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Recurrences After Low Dose Rate (LDR) Brachytherapy.. Clinical genitourinary cancer, 2023.
  49. Ma TM, Parikh NR, Philipson RG, van Dams R, Chang EM, Hegde JV, Kishan AU, Kaprealian TB, Steinberg ML, Raldow AC. Experience of Telemedicine Visits in Radiation Oncology During the COVID-19 Pandemic: A US National Survey and Lessons Learned for Incorporating Telemedicine Post-COVID-19.. Advances in radiation oncology, 2022.
  50. Ma TM, Sun Y, Malone S, Roach M, Dearnaley D, Pisansky TM, Feng FY, Sandler HM, Efstathiou JA, Syndikus I, Hall EC, Tree AC, Sydes MR, Cruickshank C, Roy S, Bolla M, Maingon P, De Reijke T, Nabid A, Carrier N, Souhami L, Zapatero A, Guerrero A, Alvarez A, Gonzalez San-Segundo C, Maldonado X, Romero T, Steinberg ML, Valle LF, Rettig MB, Nickols NG, Shoag JE, Reiter RE, Zaorsky NG, Jia AY, Garcia JA, Spratt DE, Kishan AU, Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators. Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022.
  51. Patel SA, Ma TM, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Krauss DJ, Abu-Isa EI, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, DeWeese TL, Tilki D, Ciezki JP, Karnes RJ, Nickols NG, Rettig MB, Feng FY, Berlin A, Tward JD, Davis BJ, Reiter RE, Boutros PC, Romero T, Horwitz EM, Tendulkar RD, Steinberg ML, Spratt DE, Xiang M, Kishan AU. External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.. International journal of radiation oncology, biology, physics, 2022.
  52. Ma TM, Ballas LK, Wilhalme H, Sachdeva A, Chong N, Sharma S, Yang T, Basehart V, Reiter RE, Saigal C, Chamie K, Litwin MS, Rettig MB, Nickols NG, Yoon SM, Smith L, Gao Y, Steinberg ML, Cao M, Kishan AU. Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial.. International journal of radiation oncology, biology, physics, 2022.
  53. Ma TM, Chu FI, Sandler H, Feng FY, Efstathiou JA, Jones CU, Roach M, Rosenthal SA, Pisansky T, Michalski JM, Bolla M, de Reijke TM, Maingon P, Neven A, Denham J, Steigler A, Joseph D, Nabid A, Souhami L, Carrier N, Incrocci L, Heemsbergen W, Pos FJ, Sydes MR, Dearnaley DP, Tree AC, Syndikus I, Hall E, Cruickshank C, Malone S, Roy S, Sun Y, Zaorsky NG, Nickols NG, Reiter RE, Rettig MB, Steinberg ML, Reddy VK, Xiang M, Romero T, Spratt DE, Kishan AU, Meta-analysis of Randomized trials in Cancer of the Prostate MARCAP Consortium investigators. Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).. European urology, 2022.
  54. Vapiwala N, Steinberg M, Gross C. The Accreditation Council for Graduate Medical Education's Recent Changes to Radiation Oncology Training Program Standards: Raising the Bar for Postgraduate Training Quality to Better Reflect Our Specialty and Better Serve Our Patients.. International journal of radiation oncology, biology, physics, 2022.
  55. Pham J, Savjani RR, Yoon SM, Yang T, Gao Y, Cao M, Hu P, Sheng K, Low DA, Steinberg M, Kishan AU, Yang Y. Urethral Interfractional Geometric and Dosimetric Variations of Prostate Cancer Patients: A Study Using an Onboard MRI.. Frontiers in oncology, 2022.
  56. Kishan AU, Wang X, Sun Y, Romero T, Michalski JM, Ma TM, Feng FY, Sandler HM, Bolla M, Maingon P, De Reijke T, Neven A, Steigler A, Denham JW, Joseph D, Nabid A, Carrier N, Souhami L, Sydes MR, Dearnaley DP, Syndikus I, Tree AC, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Efstathiou JA, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Xiang M, Rettig MB, Reiter RE, Zaorsky NG, Ong WL, Dess RT, Steinberg ML, Nickols NG, Roy S, Garcia JA, Spratt DE, MARCAP Consortium. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.. European urology, 2022.
  57. Valle LF, Chu FI, Smith M, Wang C, Lee P, Moghanaki D, Chino FL, Steinberg ML, Raldow AC. Characterizing Twitter Influencers in Radiation Oncology.. Advances in radiation oncology, 2022.
  58. Wu TC, Xiang M, Nickols NG, Tenn S, Agazaryan N, Hegde JV, Steinberg ML, Cao M, Kishan AU. Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison.. Advances in radiation oncology, 2022.
  59. Kundu P, Lin EY, Yoon SM, Parikh NR, Ruan D, Kishan AU, Lee A, Steinberg ML, Chang AJ. Rectal Radiation Dose and Clinical Outcomes in Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy With and Without Hydrogel.. Frontiers in oncology, 2022.
  60. Kishan AU, Steigler A, Denham JW, Zapatero A, Guerrero A, Joseph D, Maldonado X, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Tilki D, Karnes RJ, Tosoian JJ, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Jiang T, Ma TM, Xiang M, Philipson R, Chang A, Kupelian PA, Rettig MB, Feng FY, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Boutros PC, Horwitz EM, Tendulkar RD, Spratt DE, Romero T. Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.. JAMA oncology, 2022.
  61. Woods KE, Ma TM, Cook KA, Morris ED, Gao Y, Sheng K, Kishan AU, Hegde JV, Felix C, Basehart V, Narahara K, Shen Z, Tenn S, Steinberg ML, Chin RK, Cao M. A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes.. Cancers, 2022.
  62. Kane N, Romero T, Diaz-Perez S, Rettig MB, Steinberg ML, Kishan AU, Schaue D, Reiter RE, Knudsen BS, Nickols NG. Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT.. Prostate cancer and prostatic diseases, 2022.
  63. Kishan AU, Sun Y, Hartman H, Pisansky TM, Bolla M, Neven A, Steigler A, Denham JW, Feng FY, Zapatero A, Armstrong JG, Nabid A, Carrier N, Souhami L, Dunne MT, Efstathiou JA, Sandler HM, Guerrero A, Joseph D, Maingon P, de Reijke TM, Maldonado X, Ma TM, Romero T, Wang X, Rettig MB, Reiter RE, Zaorsky NG, Steinberg ML, Nickols NG, Jia AY, Garcia JA, Spratt DE, MARCAP Consortium group. Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.. The Lancet. Oncology, 2022.
  64. Xiang M, Raldow AC, Pollom EL, Steinberg ML, Kishan AU. Landscape of mortality during and within thirty days after non-palliative radiotherapy across eleven major cancer types.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2022.
  65. Kishan AU, Marco N, Schulz-Jaavall MB, Steinberg ML, Tran PT, Juarez JE, Dang A, Telesca D, Lilleby WA, Weidhaas JB. Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2022.
  66. Ma TM, Neylon J, Casado M, Sharma S, Sheng K, Low D, Yang Y, Steinberg ML, Lamb J, Cao M, Kishan AU. Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2021.
  67. Ma TM, Romero T, Nickols NG, Rettig MB, Garraway IP, Roach M, Michalski JM, Pisansky TM, Lee WR, Jones CU, Rosenthal SA, Wang C, Hartman H, Nguyen PL, Feng FY, Boutros PC, Saigal C, Chamie K, Jackson WC, Morgan TM, Mehra R, Salami SS, Vince R, Schaeffer EM, Mahal BA, Dess RT, Steinberg ML, Elashoff D, Sandler HM, Spratt DE, Kishan AU. Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.. JAMA network open, 2021.
  68. Xiang M, Ma TM, Savjani R, Pollom EL, Karnes RJ, Grogan T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Huland H, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Alam R, Schwen Z, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Chong N, Kupelian PA, Rettig MB, Zaorsky NG, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Tilki D, Czernin J, Gafita A, Romero T, Calais J, Kishan AU. Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.. JAMA network open, 2021.
  69. DeWeese TL, Beyer D, Gunderson LL, Haffty BG, Harari PM, Lawton CA, Minsky BD, Steinberg ML. The Model of an ASTRO Servant Leader.. International journal of radiation oncology, biology, physics, 2021.
  70. Agazaryan N, Tenn S, Lee C, Steinberg M, Hegde J, Chin R, Pouratian N, Yang I, Kim W, Kaprealian T. Simultaneous radiosurgery for multiple brain metastases: technical overview of the UCLA experience.. Radiation oncology (London, England), 2021.
  71. Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysl-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU. Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2021.
  72. Xiang M, Chang AJ, Chamie K, Drakaki A, Pollom EL, Steinberg ML, Kishan AU. Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer.. Clinical genitourinary cancer, 2021.
  73. Parikh NR, Clark MA, Patel P, Kafka-Peterson K, Zaide L, Ma TM, Steinberg ML, Cao M, Raldow AC, Lamb J, Kishan AU. Time-Driven Activity-Based Costing of CT-Guided vs MR-Guided Prostate SBRT.. Applied radiation oncology, 2021.
  74. Juarez JE, Romero T, Mantz CA, Pepin A, Aghdam N, Suy S, Steinberg ML, Levin-Epstein RG, Nickols NG, Kaplan ID, Meier RM, Pham HT, Linson PW, Hong RL, Buyyounouski MK, Bagshaw HP, Fuller DB, Katz AJ, Loblaw A, Collins SP, Kishan AU. Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series.. Advances in radiation oncology, 2021.
  75. Yoon SM, Luterstein E, Chu FI, Cao M, Lamb J, Agazaryan N, Low D, Raldow A, Steinberg ML, Lee P. Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis.. Cancer medicine, 2021.
  76. Pham J, Savjani RR, Gao Y, Cao M, Hu P, Sheng K, Low DA, Steinberg M, Kishan AU, Yang Y. Evaluation of T2-Weighted MRI for Visualization and Sparing of Urethra with MR-Guided Radiation Therapy (MRgRT) On-Board MRI.. Cancers, 2021.
  77. Kishan AU, Karnes RJ, Romero T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Huland H, Tran PT, Martin S, Martínez-Monge R, Krauss DJ, Abu-Isa EI, Alam R, Schwen Z, Chang AJ, Pisansky TM, Choo R, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Chong N, Kupelian PA, D'Amico AV, Rettig MB, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Tilki D. Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.. JAMA network open, 2021.
  78. van Dams R, Wu TC, Kishan AU, Raldow AC, Chu FI, Hernandez J, Cao M, Lamb JM, Mikaeilian A, Low DA, Steinberg ML, Lee P. Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: A prospective phase I trial.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2021.
  79. Cao M, Gao Y, Yoon SM, Yang Y, Sheng K, Ballas LK, Basehart V, Sachdeva A, Felix C, Low DA, Steinberg ML, Kishan AU. Interfractional Geometric Variations and Dosimetric Benefits of Stereotactic MRI Guided Online Adaptive Radiotherapy (SMART) of Prostate Bed after Radical Prostatectomy: Post-Hoc Analysis of a Phase II Trial.. Cancers, 2021.
  80. Valle LF, Chu FI, Kundu P, Yoon SM, Gilchrist T, Steinberg ML, Raldow AC. National variation in the delivery of radiation oncology procedures in the non-facility-based setting.. Cancer medicine, 2021.
  81. Gao Y, Ghodrati V, Kalbasi A, Fu J, Ruan D, Cao M, Wang C, Eilber FC, Bernthal N, Bukata S, Dry SM, Nelson SD, Kamrava M, Lewis J, Low DA, Steinberg M, Hu P, Yang Y. Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentation.. Medical physics, 2021.
  82. Ma TM, Lamb JM, Casado M, Wang X, Basehart TV, Yang Y, Low D, Sheng K, Agazaryan N, Nickols NG, Cao M, Steinberg ML, Kishan AU. Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.. BMC cancer, 2021.
  83. Philipson RG, Romero T, Wong JK, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Valle L, Chong N, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Tilki D, Karnes RJ, Klein EA, Tosoian JJ, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Kupelian PA, Rettig MB, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Kishan AU. Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.. European urology, 2021.
  84. Woods K, Chin RK, Cook KA, Sheng K, Kishan AU, Hegde JV, Tenn S, Steinberg ML, Cao M. Automated Non-Coplanar VMAT for Dose Escalation in Recurrent Head and Neck Cancer Patients.. Cancers, 2021.
  85. Chow PE, Chu FI, Agazaryan N, Cao M, Tyran M, Yang Y, Low D, Raldow A, Lee P, Steinberg M, Lamb JM. Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System.. Advances in radiation oncology, 2021.
  86. Ma TM, Gafita A, Shabsovich D, Juarez J, Grogan TR, Thin P, Armstrong W, Sonni I, Nguyen K, Lok V, Reiter RE, Rettig MB, Steinberg ML, Kupelian PA, Yang DD, Muralidhar V, Chu C, Feng F, Savjani R, Deng J, Parikh NR, Nickols NG, Elashoff D, Czernin J, Calais J, Kishan AU. Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging.. European urology oncology, 2021.
  87. Yoon SM, Chu FI, Ruan D, Steinberg ML, Raldow A, Lee P. Assessment of Toxic Effects Associated With Dose-Fractionated Radiotherapy Among Patients With Cancer and Comorbid Collagen Vascular Disease.. JAMA network open, 2021.
  88. van Dams R, Jiang NY, Fuller DB, Loblaw A, Jiang T, Katz AJ, Collins SP, Aghdam N, Suy S, Stephans KL, Yuan Y, Nickols NG, Murthy V, Telkhade TP, Kupelian PA, Steinberg ML, Romero T, Kishan AU. Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.. International journal of radiation oncology, biology, physics, 2021.
  89. Iwamoto KS, Sandstrom RE, Bryan M, Liu Y, Elgart SR, Sheng K, Steinberg ML, McBride WH, Low DA. Weak Magnetic Fields Enhance the Efficacy of Radiation Therapy.. Advances in radiation oncology, 2021.
  90. Philipson RG, Wu AD, Curtis WC, Jablonsky DJ, Hegde JV, McCloskey SA, Kaprealian TB, Steinberg ML, Kishan AU, Raldow AC. A Practical Guide for Navigating the Design, Build, and Clinical Integration of Electronic Patient-Reported Outcomes in the Radiation Oncology Department.. Practical radiation oncology, 2021.
  91. Valle LF, Chu FI, Yoon SM, Kundu P, Venkat P, Gilchrist T, Steinberg ML, Raldow AC. Provider-Level Variation in Treatment Planning of Radiation Oncology Procedures in the United States.. JCO oncology practice, 2021.
  92. Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ, Reiter RE, Rettig M, Calais J, Nickols NG, Dess RT, Spratt DE, Steinberg ML, Nguyen PL, Davis BJ, Zaorsky NG, Kishan AU. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).. European urology, 2020.
  93. Wu TC, McCloskey SA, Wallner PE, Steinberg ML, Raldow AC. The Declining Residency Applicant Pool: A Multi-Institutional Medical Student Survey to Identify Precipitating Factors.. Advances in radiation oncology, 2020.
  94. Levin-Epstein RG, Jiang NY, Wang X, Upadhyaya SK, Collins SP, Suy S, Aghdam N, Mantz C, Katz AJ, Miszczyk L, Napieralska A, Namysl-Kaletka A, Prionas N, Bagshaw H, Buyyounouski MK, Cao M, Agazaryan N, Dang A, Yuan Y, Kupelian PA, Zaorsky NG, Spratt DE, Mohamad O, Feng FY, Mahal BA, Boutros PC, Kishan AU, Juarez J, Shabsovich D, Jiang T, Kahlon S, Patel A, Patel J, Nickols NG, Steinberg ML, Fuller DB, Kishan AU. Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020.
  95. Parikh NR, Chang EM, Kishan AU, Kaprealian TB, Steinberg ML, Raldow AC. Time-Driven Activity-Based Costing Analysis of Telemedicine Services in Radiation Oncology.. International journal of radiation oncology, biology, physics, 2020.
  96. Kundu P, Jung OS, Valle LF, Edmondson AC, Agazaryan N, Hegde J, Steinberg M, Raldow A. Missing the Near Miss: Recognizing Valuable Learning Opportunities in Radiation Oncology.. Practical radiation oncology, 2020.
  97. Wallner PE, Lieto RP, Dillehay GL, Ghesani MV, Rosenthal SA, Rosenzweig KE, Steinberg ML, Yoo DC, Small W. Potential Significant Changes in Nuclear Regulatory Commission Policies Regarding Training and Experience Requirements for the Use of Radiopharmaceuticals.. Journal of the American College of Radiology : JACR, 2020.
  98. Gao Y, Kalbasi A, Hsu W, Ruan D, Fu J, Shao J, Cao M, Wang C, Eilber FC, Bernthal N, Bukata S, Dry SM, Nelson SD, Kamrava M, Lewis J, Low DA, Steinberg M, Hu P, Yang Y. Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs.. Physics in medicine and biology, 2020.
  99. Chin R, Hayase J, Hu P, Cao M, Deng J, Ajijola O, Do D, Vaseghi M, Buch E, Khakpour H, Fujimura O, Krokhaleva Y, Macias C, Sorg J, Gima J, Pavez G, Boyle NG, Steinberg M, Shivkumar K, Bradfield JS. Non-invasive stereotactic body radiation therapy for refractory ventricular arrhythmias: an institutional experience.. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2020.
  100. Chang EM, Shaverdian N, Capiro N, Steinberg ML, Raldow AC. Cost Effectiveness of External Beam Radiation Therapy versus Percutaneous Image-Guided Cryoablation for Palliation of Uncomplicated Bone Metastases.. Journal of vascular and interventional radiology : JVIR, 2020.
  101. Levin-Epstein R, Cook RR, Wong JK, Stock RG, Jeffrey Demanes D, Collins SP, Aghdam N, Suy S, Mantz C, Katz AJ, Nickols NG, Miszczyk L, Napieralska A, Namysl-Kaletka A, Prionas ND, Bagshaw H, Buyyounouski MK, Cao M, Mahal BA, Shabsovich D, Dang A, Yuan Y, Rettig MB, Chang AJ, Jackson WC, Spratt DE, Lehrer EJ, Zaorsky NG, Kupelian PA, Steinberg ML, Horwitz EM, Jiang NY, Kishan AU. Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020.
  102. Nickols NG, Ganapathy E, Nguyen C, Kane N, Lin L, Diaz-Perez S, Nazarian R, Mathis C, Felix C, Basehart V, Zomorodian N, Kwak J, Kishan AU, King CR, Kupelian PA, Rettig MB, Steinberg ML, Cao M, Knudsen BS, Chu FI, Romero T, Elashoff D, Reiter RE, Schaue D. The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells.. Prostate cancer and prostatic diseases, 2020.
  103. Parikh NR, Kundu P, Levin-Epstein R, Chang EM, Agazaryan N, Hegde JV, Steinberg ML, Tenn SE, Kaprealian TB. Time-Driven Activity-Based Costing Comparison of Stereotactic Radiosurgery to Multiple Brain Lesions Using Single-Isocenter Versus Multiple-Isocenter Technique.. International journal of radiation oncology, biology, physics, 2020.
  104. Qi XS, Chu FI, Zhang Z, Chin RK, Raldow A, Kishan AU, Lee P, Chang A, Kalbasi A, Kamrava M, Steinberg ML, Low DA. Clinical Development and Evaluation of Megavoltage Topogram for Fast Patient Alignment on Helical Tomotherapy.. Advances in radiation oncology, 2020.
  105. Parikh NR, Kishan AU, Kane N, Diaz-Perez S, Ganapathy E, Nazarian R, Felix C, Mathis C, Bradley M, Sachdeva A, Wyatt B, Basehart V, Zomorodian N, Lin L, King CR, Kupelian PA, Rettig MB, Steinberg ML, Cao M, Knudsen BS, Elashoff D, Schaue D, Reiter RE, Nickols NG. Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer.. International journal of radiation oncology, biology, physics, 2020.
  106. Parikh NR, Lee PP, Raman SS, Cao M, Lamb J, Tyran M, Chin W, Gilchrist T, Agazaryan N, Mittauer K, Steinberg ML, Raldow AC. Time-Driven Activity-Based Costing Comparison of CT-Guided Versus MR-Guided SBRT.. JCO oncology practice, 2020.
  107. Parikh NR, Chang EM, Nickols NG, Rettig MB, Raldow AC, Steinberg ML, Koontz BF, Vapiwala N, Deville C, Feng FY, Spratt DE, Reiter RE, Phillips R, Ost P, Tran PT, Kishan AU. Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer.. International journal of radiation oncology, biology, physics, 2020.
  108. Valle LF, Ruan D, Dang A, Levin-Epstein RG, Patel AP, Weidhaas JB, Nickols NG, Lee PP, Low DA, Qi XS, King CR, Steinberg ML, Kupelian PA, Cao M, Kishan AU. Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy.. Frontiers in oncology, 2020.
  109. Pan X, Levin-Epstein R, Huang J, Ruan D, King CR, Kishan AU, Steinberg ML, Qi XS. Dosimetric predictors of patient-reported toxicity after prostate stereotactic body radiotherapy: Analysis of full range of the dose-volume histogram using ensemble machine learning.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020.
  110. Levin-Epstein R, Qiao-Guan G, Juarez JE, Shen Z, Steinberg ML, Ruan D, Valle L, Nickols NG, Kupelian PA, King CR, Cao M, Kishan AU. Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer.. Frontiers in oncology, 2020.
  111. Yoon S, Cao M, Aghdam N, Shabsovich D, Kahlon S, Ballas L, Collins S, Steinberg ML, Kishan AU. Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020.
  112. Agazaryan N, Chow P, Lamb J, Cao M, Raldow A, Beron P, Hegde J, Steinberg M. The Timeliness Initiative: Continuous Process Improvement for Prompt Initiation of Radiation Therapy Treatment.. Advances in radiation oncology, 2020.
  113. Kalbasi A, Kamrava M, Chu FI, Telesca D, Van Dams R, Yang Y, Ruan D, Nelson SD, Dry SM, Hernandez J, Chmielowski B, Singh AS, Bukata SV, Bernthal NM, Steinberg ML, Weidhaas JB, Eilber FC. A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma.. Clinical cancer research : an official journal of the American Association for Cancer Research, 2020.
  114. Babayan RK, Steinberg ML, Miller LE. Re: Aminsharifi et al., Major Complications and Adverse Events Related to the Injection of the SpaceOAR Hydrogel System Before Radiotherapy for Prostate Cancer: Review of the Manufacturer and User Facility Device Experience Database (From: Aminsharifi A, Kotamarti S, Silver D, et al., J Endourol 2019;33:868-871; DOI: 10.1089/end.2019.0431).. Journal of endourology, 2020.
  115. Wang C, Kishan AU, Raldow A, Beron P, Wong DJ, St John M, Steinberg ML, Chin R. Addition of Chemotherapy Is Associated With Decreased Survival in Early-Stage (T1-2N0M0) Glottic Squamous Cell Carcinoma Treated With Definitive Radiotherapy.. JCO precision oncology, 2019.
  116. Attiah M, Sandler K, Medina R, Gaonkar B, McArthur D, Farha G, Selch M, De Salles A, Tenn S, Agazaryan N, Lee P, Steinberg M, Lu D, Macyszyn L, Kaprealian T. Comparison of Clinical Outcomes Stratified by Target Delineation for Patients Undergoing Stereotactic Body Radiotherapy for Spinal Metastases.. World neurosurgery, 2019.
  117. Kishan AU, Chu FI, King CR, Seiferheld W, Spratt DE, Tran P, Wang X, Pugh SE, Sandler KA, Bolla M, Maingon P, De Reijke T, Nickols NG, Rettig M, Drakaki A, Liu ST, Reiter RE, Chang AJ, Feng FY, Sajed D, Nguyen PL, Kupelian PA, Steinberg ML, Boutros PC, Elashoff D, Collette L, Sandler HM. Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.. European urology, 2019.
  118. Dang AT, Levin-Epstein RG, Shabsovich D, Cao M, King C, Chu FI, Mantz CA, Stephans KL, Reddy CA, Loblaw DA, Cheung P, Scorsetti M, Cozzi L, DeNittis AS, Wang Y, Zaorsky N, Nickols NG, Kupelian PA, Steinberg ML, Kishan AU. Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer.. Advances in radiation oncology, 2019.
  119. Luterstein E, Cao M, Lamb JM, Raldow A, Low D, Steinberg ML, Lee P. Clinical Outcomes Using Magnetic Resonance-Guided Stereotactic Body Radiation Therapy in Patients With Locally Advanced Cholangiocarcinoma.. Advances in radiation oncology, 2019.
  120. Jiang NY, Dang AT, Yuan Y, Chu FI, Shabsovich D, King CR, Collins SP, Aghdam N, Suy S, Mantz CA, Miszczyk L, Napieralska A, Namysl-Kaletka A, Bagshaw H, Prionas N, Buyyounouski MK, Jackson WC, Spratt DE, Nickols NG, Steinberg ML, Kupelian PA, Kishan AU. Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy.. International journal of radiation oncology, biology, physics, 2019.
  121. Kishan AU, Wang C, Steinberg ML, Spratt DE. Key considerations when reviewing subsequent primary cancers following radiotherapy.. The Lancet. Oncology, 2019.
  122. Yuan Y, Aghdam N, King CR, Fuller DB, Weng J, Chu FI, Mardirossian G, Patel A, Nickols NG, Kupelian PA, Steinberg ML, Collins SP, Kishan AU. Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials.. International journal of radiation oncology, biology, physics, 2019.
  123. Wallner PE, Lieto RP, Dillehay GL, Ghesani MV, Rosenthal SA, Rosenzweig KE, Steinberg ML, Yoo DC. Training and Education Requirements for Authorized Users of Therapeutic Radiopharmaceuticals: Changes Under Consideration for 10CFR35.390 and Their Potential Impact.. Journal of the American College of Radiology : JACR, 2019.
  124. Wang C, Kishan AU, Yu JB, Raldow A, King CR, Iwamoto KS, Chu FI, Steinberg ML, Kupelian PA. Association between Long-Term Second Malignancy Risk and Radiation: A Comprehensive Analysis of the Entire Surveillance, Epidemiology, and End Results Database (1973-2014).. Advances in radiation oncology, 2019.
  125. Qi XS, Yang L, Lee P, O'Connell D, Chu FI, Steinberg ML, Low DA. Fast, Low-Dose Megavoltage-Topogram Localization on TomoTherapy: Initial Clinical Experience With Mesothelioma Patients.. Practical radiation oncology, 2019.
  126. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.. European urology, 2019.
  127. Shaverdian N, Hegde JV, Felix C, Hsu S, Basehart V, Steinberg ML, Chen AM. Patient perspectives and treatment regret after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal cancer: Findings from a phase II trial.. Head & neck, 2019.
  128. Kishan AU, Tyran M, Weng J, Upadhyaya S, Lamb J, Steinberg M, King C, Cao M. Stereotactic body radiotherapy to the prostate and pelvic lymph nodes: A detailed dosimetric analysis of a phase II prospective trial.. The British journal of radiology, 2019.
  129. Valle L, Weng J, Jagsi R, Chu FI, Ahmad S, Steinberg M, Raldow A. Assessment of Differences in Clinical Activity and Medicare Payments Among Female and Male Radiation Oncologists.. JAMA network open, 2019.
  130. Wang C, Raldow AC, Nickols NG, Nguyen PL, Spratt DE, Dess RT, Yu JB, King CR, Chu FI, Chamie K, Litwin MS, Saigal CS, Reiter RE, Liu ST, Rettig MB, Chang AJ, Steinberg ML, Kupelian PA, Kishan AU. Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer.. European urology oncology, 2019.
  131. Steinberg ML, McBride WH, Vlashi E, Pajonk F. If It Seems Too Good to Be True….. International journal of radiation oncology, biology, physics, 2019.
  132. Kishan AU, Dang A, Katz AJ, Mantz CA, Collins SP, Aghdam N, Chu FI, Kaplan ID, Appelbaum L, Fuller DB, Meier RM, Loblaw DA, Cheung P, Pham HT, Shaverdian N, Jiang N, Yuan Y, Bagshaw H, Prionas N, Buyyounouski MK, Spratt DE, Linson PW, Hong RL, Nickols NG, Steinberg ML, Kupelian PA, King CR. Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.. JAMA network open, 2019.
  133. Weng JK, Valle LF, Nam GE, Chu FI, Steinberg ML, Raldow AC. Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists.. JAMA network open, 2019.
  134. Kishan AU, Wang X, Seiferheld W, Collette L, Sandler KA, Sandler HM, Bolla M, Maingon P, De Reijke T, Hanks GE, Nickols NG, Rettig M, Drakaki A, Reiter RE, Spratt DE, Kupelian PA, Steinberg ML, King CR. Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis.. JAMA oncology, 2019.
  135. Chang EM, Punglia RS, Steinberg ML, Raldow AC. Cost Effectiveness of the Oncotype DX Genomic Prostate Score for Guiding Treatment Decisions in Patients With Early Stage Prostate Cancer.. Urology, 2018.
  136. Chen AM, Kupelian PA, Wang PC, Steinberg ML. Development of a Radiation Oncology-Specific Prospective Data Registry for Research and Quality Improvement: A Clinical Workflow-Based Solution.. JCO clinical cancer informatics, 2018.
  137. Pennington JD, Eilber FC, Eilber FR, Singh AS, Reed JP, Chmielowski B, Eckardt JJ, Bukata SV, Bernthal NM, Federman N, Nelson SD, Dry SM, Wang PC, Luu M, Selch MT, Steinberg ML, Kalbasi A, Kamrava M. Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas.. American journal of clinical oncology, 2018.
  138. Shaverdian N, Chang EM, Chu FI, Morasso EG, Pfeffer MA, Cheng EM, Wu A, McCloskey SA, Raldow AC, Steinberg ML. Impact of Open Access to Physician Notes on Radiation Oncology Patients: Results from an Exploratory Survey.. Practical radiation oncology, 2018.
  139. Shaverdian N, Kishan AU, Veruttipong D, Demanes DJ, Kupelian P, McCloskey S, Steinberg ML, King CR. Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate Cancer.. American journal of clinical oncology, 2018.
  140. Odei B, Rwigema JC, Eilber FR, Eilber FC, Selch M, Singh A, Chmielowski B, Nelson SD, Wang PC, Steinberg M, Kamrava M. Predictors of Local Recurrence in Patients With Myxofibrosarcoma.. American journal of clinical oncology, 2018.
  141. Tyran M, Jiang N, Cao M, Raldow A, Lamb JM, Low D, Luterstein E, Steinberg ML, Lee P. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2018.
  142. Kang JJ, Reiter RE, Steinberg ML, King CR. First Postprostatectomy Ultrasensitive Prostate-specific Antigen Predicts Survival in Patients with High-risk Prostate Cancer Pathology.. European urology oncology, 2018.
  143. Kishan AU, Duchesne G, Wang PC, Rwigema JM, Kishan AU, Saigal C, Rettig M, Steinberg ML, King CR. Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer.. American journal of clinical oncology, 2018.
  144. Sandler KA, Mitchell SA, Basch E, Raldow AC, Steinberg ML, Sharif J, Cook RR, Kupelian PA, McCloskey SA. Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation Oncology.. International journal of radiation oncology, biology, physics, 2018.
  145. Kishan AU, Duchesne G, Wang PC, Rwigema JM, Saigal C, Rettig M, Steinberg ML, King CR. Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?. American journal of clinical oncology, 2018.
  146. Han F, Zhou Z, Du D, Gao Y, Rashid S, Cao M, Shaverdian N, Hegde JV, Steinberg M, Lee P, Raldow A, Low DA, Sheng K, Yang Y, Hu P. Respiratory motion-resolved, self-gated 4D-MRI using Rotating Cartesian K-space (ROCK): Initial clinical experience on an MRI-guided radiotherapy system.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2018.
  147. Gao Y, Zhou Z, Han F, Cao M, Shaverdian N, Hegde JV, Bista BB, Steinberg M, Lee P, Raldow A, Low DA, Yang Y, Hu P. Accelerated 3D bSSFP imaging for treatment planning on an MRI-guided radiotherapy system.. Medical physics, 2018.
  148. Hegde JV, Collins SP, Fuller DB, King CR, Demanes DJ, Wang PC, Kupelian PA, Steinberg ML, Kamrava M. A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy.. American journal of clinical oncology, 2018.
  149. Levin-Epstein R, Cao M, Lee P, Steinberg ML, Lamb J, Raldow AC. Magnetic Resonance-guided Inter-fraction Monitoring Opens Doors to Delivering Safer Reirradiation: An Illustrative Case Report and Discussion.. Cureus, 2018.
  150. Calais J, Kishan AU, Cao M, Fendler WP, Eiber M, Herrmann K, Ceci F, Reiter RE, Rettig MB, Hegde JV, Shaverdian N, King CR, Steinberg ML, Czernin J, Nickols NG. Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018.
  151. Hegde JV, Cao M, Yu VY, Kishan AU, Shaverdian N, Lamb J, Steinberg ML. Magnetic Resonance Imaging Guidance Mitigates the Effects of Intrafraction Prostate Motion During Stereotactic Body Radiotherapy for Prostate Cancer.. Cureus, 2018.
  152. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.. International journal of radiation oncology, biology, physics, 2018.
  153. Tyran M, Cao M, Raldow AC, Dang A, Lamb J, Low DA, Steinberg ML, Lee P. Stereotactic Magnetic Resonance-guided Online Adaptive Radiotherapy for Oligometastatic Breast Cancer: A Case Report.. Cureus, 2018.
  154. Kishan AU, Tyran M, Steinberg ML, Holden SB, Cao M. MRI-guided Dose-escalated Salvage Radiotherapy for Bulky Bladder Neck Recurrence of Prostate Cancer.. Cureus, 2018.
  155. Sandler KA, Abtin F, Suh R, Cook RR, Felix C, Lee JM, Garon EB, Wu J, Luterstein EM, Agazaryan N, Tenn SE, Lee C, Steinberg ML, Lee P. A Prospective Phase 2 Study Evaluating Safety and Efficacy of Combining Stereotactic Body Radiation Therapy With Heat-based Ablation for Centrally Located Lung Tumors.. International journal of radiation oncology, biology, physics, 2018.
  156. Luterstein E, Cao M, Lamb J, Raldow AC, Low DA, Steinberg ML, Lee P. Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer: A Promising Approach.. Cureus, 2018.
  157. Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.. JAMA, 2018.
  158. Shaverdian N, Wang X, Hegde JV, Aledia C, Weidhaas JB, Steinberg ML, McCloskey SA. The patient's perspective on breast radiotherapy: Initial fears and expectations versus reality.. Cancer, 2018.
  159. Kang JJ, Steinberg ML, Kupelian P, Alexander S, King CR. Whole Versus Partial Bladder Radiation: Use of an Image-guided Hypofractionated IMRT Bladder-preservation Protocol.. American journal of clinical oncology, 2018.
  160. Kang JJ, Reiter RE, Kummer N, DeKernion J, Steinberg ML, King CR. Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical Prostatectomy.. American journal of clinical oncology, 2018.
  161. Calais J, Czernin J, Cao M, Kishan AU, Hegde JV, Shaverdian N, Sandler K, Chu FI, King CR, Steinberg ML, Rauscher I, Schmidt-Hegemann NS, Poeppel T, Hetkamp P, Ceci F, Herrmann K, Fendler WP, Eiber M, Nickols NG. 68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017.
  162. Kishan AU, Cheng EM, Schmidt E, Saigal C, Reiter RE, Kupelian PA, Steinberg ML, King CR. Use of the Electronic Medical Record to Facilitate Intervention for Patients With Rising Prostate-Specific Antigen Values After Radical Prostatectomy: A Feasibility Study.. JCO clinical cancer informatics, 2017.
  163. Hegde JV, Shaverdian N, Daly ME, Felix C, Wong DL, Rosove MH, Garst JH, Wang PC, Veruttipong D, Rao S, Fragoso RC, Riess JW, Steinberg ML, Chen AM. Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.. Cancer, 2017.
  164. Hegde JV, Wang X, Attai DJ, DiNome ML, Kusske A, Hoyt AC, Hurvitz SA, Weidhaas JB, Steinberg ML, McCloskey SA. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.. Clinical breast cancer, 2017.
  165. Qi XS, Pajonk F, McCloskey S, Low DA, Kupelian P, Steinberg M, Sheng K. Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2017.
  166. Lamb J, Cao M, Kishan A, Agazaryan N, Thomas DH, Shaverdian N, Yang Y, Ray S, Low DA, Raldow A, Steinberg ML, Lee P. Online Adaptive Radiation Therapy: Implementation of a New Process of Care.. Cureus, 2017.
  167. Hegde JV, Demanes DJ, Veruttipong D, Raince J, Park SJ, Raman SS, Nickols NG, King CR, Kishan AU, Steinberg ML, Kamrava M. Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.. Brachytherapy, 2017.
  168. Chen AM, Beron PJ, Wong D, Rosove MH, Rao SD, Steinberg ML, Kupelian PA, Daly ME. Prospective radiotherapy for patients with oropharyngeal carcinoma - Authors' reply.. The Lancet. Oncology, 2017.
  169. Hegde JV, Wang X, Attai DJ, DiNome ML, Kusske A, Hoyt AC, Hurvitz SA, Weidhaas JB, Steinberg ML, McCloskey SA. Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer.. Breast cancer research and treatment, 2017.
  170. Hegde JV, Veruttipong D, Said JW, Reiter RE, Steinberg ML, King CR, Kishan AU. Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer.. Urology, 2017.
  171. Shaverdian N, Steinberg ML, King CR. In Reply to Scott.. International journal of radiation oncology, biology, physics, 2017.
  172. Chen AM, Felix C, Wang PC, Hsu S, Basehart V, Garst J, Beron P, Wong D, Rosove MH, Rao S, Melanson H, Kim E, Palmer D, Qi L, Kelly K, Steinberg ML, Kupelian PA, Daly ME. Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.. The Lancet. Oncology, 2017.
  173. Wang C, Kishan AU, Kamrava M, Steinberg ML, King CR. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.. International journal of radiation oncology, biology, physics, 2017.
  174. Shaverdian N, Yoo SM, Cook R, Chang EM, Jiang N, Yuan Y, Sandler K, Steinberg M, Lee P. Gaps in Radiation Therapy Awareness: Results From an Educational Multi-institutional Survey of US Internal Medicine Residents.. International journal of radiation oncology, biology, physics, 2017.
  175. Walling AM, Beron PJ, Kaprealian T, Kupelian PA, Wenger NS, McCloskey SA, King CR, Steinberg M. Considerations for Quality Improvement in Radiation Oncology Therapy for Patients with Uncomplicated Painful Bone Metastases.. Journal of palliative medicine, 2017.
  176. Chen AM, Cao M, Hsu S, Lamb J, Mikaeilian A, Yang Y, Agazaryan N, Low DA, Steinberg ML. Magnetic resonance imaging guided reirradiation of recurrent and second primary head and neck cancer.. Advances in radiation oncology, 2017.
  177. Sandler KA, Shaverdian N, Cook RR, Kishan AU, King CR, Yang I, Steinberg ML, Lee P. Treatment trends for patients with brain metastases: Does practice reflect the data?. Cancer, 2017.
  178. Wang C, King CR, Kamrava M, Iwamoto KS, Chen AM, Low D, Kupelian PA, Steinberg ML. Pattern of solid and hematopoietic second malignancy after local therapy for prostate cancer.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2017.
  179. Mesko S, Sandler K, Cohen J, Konecny G, Steinberg M, Kamrava M. Clinical Outcomes for Stereotactic Ablative Radiotherapy in Oligometastatic and Oligoprogressive Gynecological Malignancies.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017.
  180. Kishan AU, Steinberg ML, Kupelian PA, King CR. Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau's Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73.. European urology, 2017.
  181. Shaverdian N, Yang Y, Hu P, Hart S, Sheng K, Lamb J, Cao M, Agazaryan N, Thomas D, Steinberg M, Low DA, Lee P. Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer.. The British journal of radiology, 2017.
  182. Wang C, Kamrava M, King C, Steinberg ML. Racial Disparity in Prostate Cancer-Specific Mortality for High-Risk Prostate Cancer: A Population-Based Study.. Cureus, 2017.
  183. Kishan AU, Kupelian PA, Steinberg ML, King CR. Urinary toxicity after stereotactic body radiotherapy: The boy who cried wolf?. Cancer, 2016.
  184. Patel S, Demanes DJ, Ragab O, Zhang M, Veruttipong D, Nguyen K, Park SJ, Marks L, Pantuck A, Steinberg M, Kamrava M. High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer.. Brachytherapy, 2016.
  185. Shaverdian N, Verruttipong D, Wang PC, Kishan AU, Demanes DJ, McCloskey S, Kupelian P, Steinberg ML, King CR. Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.. International journal of radiation oncology, biology, physics, 2016.
  186. Smith GL, Ganz PA, Bekelman JE, Chmura SJ, Dignam JJ, Efstathiou JA, Jagsi R, Johnstone PA, Steinberg ML, Williams SB, Yu JB, Zietman AL, Weichselbaum RR, Tina Shih YC. Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.. International journal of radiation oncology, biology, physics, 2016.
  187. Fallon J, Park SJ, Yang L, Veruttipong D, Zhang M, Van T, Wang PC, Fekete AM, Cambeiro M, Kamrava M, Steinberg ML, Demanes DJ. Long term results from a prospective database on high dose rate (HDR) interstitial brachytherapy for primary cervical carcinoma.. Gynecologic oncology, 2016.
  188. Shaverdian N, Veruttipong D, Wang J, Kupelian P, Steinberg M, Lee P. Location Matters: Stage I Non-Small-cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes.. Clinical lung cancer, 2016.
  189. Ilg AM, Laviana AA, Kamrava M, Veruttipong D, Steinberg M, Park SJ, Burke MA, Niedzwiecki D, Kupelian PA, Saigal C. Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancer.. Brachytherapy, 2016.
  190. Qi XS, Wang JP, Gomez CL, Shao W, Xu X, King C, Low DA, Steinberg M, Kupelian P. Plan quality and dosimetric association of patient-reported rectal and urinary toxicities for prostate stereotactic body radiotherapy.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2016.
  191. Chow PE, Thomas DH, Agazaryan N, Cao M, Low DA, Yang Y, Steinberg ML, Lee P, Lamb JM. Technical Note: Dosimetric effects of couch position variability on treatment plan quality with an MRI-guided Co-60 radiation therapy machine.. Medical physics, 2016.
  192. Kishan AU, Shaikh T, Wang PC, Reiter RE, Said J, Raghavan G, Nickols NG, Aronson WJ, Sadeghi A, Kamrava M, Demanes DJ, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis.. European urology, 2016.
  193. Shaverdian N, Veruttipong D, Wang J, Kupelian P, Steinberg M, Lee P. Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2016.
  194. Kishan AU, Wang PC, Sharif J, Kupelian PA, Steinberg ML, McCloskey SA. Clinical Indicators of Psychosocial Distress Predict for Acute Radiation-Induced Fatigue in Patients Receiving Adjuvant Radiation Therapy for Breast Cancer: An Analysis of Patient-Reported Outcomes.. International journal of radiation oncology, biology, physics, 2016.
  195. Shaverdian N, Tenn S, Veruttipong D, Wang J, Hegde J, Lee C, Cao M, Agazaryan N, Steinberg M, Kupelian P, Lee P. The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.. The British journal of radiology, 2016.
  196. Merna C, Rwigema JC, Cao M, Wang PC, Kishan AU, Michailian A, Lamb J, Sheng K, Agazaryan N, Low DA, Kupelian P, Steinberg ML, Lee P. A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancer.. Medical dosimetry : official journal of the American Association of Medical Dosimetrists, 2016.
  197. Kishan AU, Steinberg ML, Kupelian PA, King CR. In Regard to Bauman et al.. International journal of radiation oncology, biology, physics, 2015.
  198. Kishan AU, Wang PC, Upadhyaya SK, Hauswald H, Demanes DJ, Nickols NG, Kamrava M, Sadeghi A, Kupelian PA, Steinberg ML, Prionas ND, Buyyounouski MK, King CR. SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer.. Practical radiation oncology, 2015.
  199. Laviana AA, Ilg AM, Veruttipong D, Tan HJ, Burke MA, Niedzwiecki DR, Kupelian PA, King CR, Steinberg ML, Kundavaram CR, Kamrava M, Kaplan AL, Moriarity AK, Hsu W, Margolis DJ, Hu JC, Saigal CS. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.. Cancer, 2015.
  200. King CR, Kamrava M, Wang PC, Steinberg ML. In Regard to Mariados et al.. International journal of radiation oncology, biology, physics, 2015.
  201. Kishan AU, Park SJ, King CR, Roberts K, Kupelian PA, Steinberg ML, Kamrava M. Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy.. The British journal of radiology, 2015.
  202. Wallner PE, Steinberg ML. "Feeding the Beast" Is Not the Road to Value.. International journal of radiation oncology, biology, physics, 2015.
  203. Wallner PE, Kupelian P, Erickson B, Alektiar KM, Laszakovits D, Henson TM, Wang PC, Steinberg ML. The American Board of Radiology Focused Practice Recognition in Brachytherapy (FPRB) Program: Opportunities lost, lessons learned, and future implications.. Practical radiation oncology, 2015.
  204. Hauswald H, Kamrava MR, Fallon JM, Wang PC, Park SJ, Van T, Borja L, Steinberg ML, Demanes DJ. High-Dose-Rate Monotherapy for Localized Prostate Cancer: 10-Year Results.. International journal of radiation oncology, biology, physics, 2015.
  205. Kishan AU, Cameron RB, Wang PC, Alexander S, Qi SX, Low DA, Kupelian PA, Steinberg ML, Lee JM, Selch MT, Lee P. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.. Practical radiation oncology, 2015.
  206. Shaverdian N, Wang PC, Steinberg M, Lee P. The patient's perspective on stereotactic body radiation therapy (SBRT) vs. surgery for treatment of early stage non-small cell lung cancer (NSCLC).. Lung cancer (Amsterdam, Netherlands), 2015.
  207. Wallner PE, Steinberg ML, McBride WH, Hahn SM, Zietman AL. A fork in the road: choosing the path of relevance.. International journal of radiation oncology, biology, physics, 2015.
  208. Qi XS, Santhanam A, Neylon J, Min Y, Armstrong T, Sheng K, Staton RJ, Pukala J, Pham A, Low DA, Lee SP, Steinberg M, Manon R, Chen AM, Kupelian P. Near Real-Time Assessment of Anatomic and Dosimetric Variations for Head and Neck Radiation Therapy via Graphics Processing Unit-based Dose Deformation Framework.. International journal of radiation oncology, biology, physics, 2015.
  209. Kishan AU, Cao M, Wang PC, Mikaeilian AG, Tenn S, Rwigema JM, Sheng K, Low DA, Kupelian PA, Steinberg ML, Lee P. Feasibility of magnetic resonance imaging-guided liver stereotactic body radiation therapy: A comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based intensity modulated radiation therapy.. Practical radiation oncology, 2015.
  210. Qi XS, Ruan D, Lee SP, Pham A, Kupelian P, Low DA, Steinberg M, Demarco J. Dependence of achievable plan quality on treatment technique and planning goal refinement: a head-and-neck intensity modulated radiation therapy application.. International journal of radiation oncology, biology, physics, 2015.
  211. Kishan AU, Lamb JM, Jani SS, Kang JJ, Steinberg ML, King CR. Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy.. International journal of radiation oncology, biology, physics, 2015.
  212. Kishan AU, Cao M, Mikaeilian AG, Low DA, Kupelian PA, Steinberg ML, Kamrava M. Dosimetric feasibility of magnetic resonance imaging-guided tri-cobalt 60 preoperative intensity modulated radiation therapy for soft tissue sarcomas of the extremity.. Practical radiation oncology, 2015.
  213. Gomez CL, Xu X, Qi XS, Wang PC, Kupelian P, Steinberg M, King CR. Dosimetric parameters predict short-term quality-of-life outcomes for patients receiving stereotactic body radiation therapy for prostate cancer.. Practical radiation oncology, 2015.
  214. Demanes DJ, Banerjee R, Cahan BL, Lee SP, Park SJ, Fallon JM, Reyes P, Van TQ, Steinberg ML, Kamrava MR. Ureteral stent insertion for gynecologic interstitial high-dose-rate brachytherapy.. Brachytherapy, 2014.
  215. Rwigema JC, Nguyen D, Heron DE, Chen AM, Lee P, Wang PC, Vargo JA, Low DA, Huq MS, Tenn S, Steinberg ML, Kupelian P, Sheng K. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.. International journal of radiation oncology, biology, physics, 2014.
  216. Coleman CN, Formenti SC, Williams TR, Petereit DG, Soo KC, Wong J, Chao N, Shulman LN, Grover S, Magrath I, Hahn S, Liu FF, DeWeese T, Khleif SN, Steinberg M, Roth L, Pistenmaa DA, Love RR, Mohiuddin M, Vikram B. The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries.. Frontiers in oncology, 2014.
  217. Kang JJ, Reiter RE, Steinberg ML, King CR. Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapy.. The Journal of urology, 2014.
  218. Hahn C, Kavanagh B, Bhatnagar A, Jacobson G, Lutz S, Patton C, Potters L, Steinberg M. Choosing wisely: the American Society for Radiation Oncology's top 5 list.. Practical radiation oncology, 2014.
  219. Rwigema JM, King C, Wang PC, Kamrava M, Kupelian P, Steinberg ML, Lee P. Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control.. Practical radiation oncology, 2014.
  220. Kupelian P, Mehta NH, King C, Steinberg M, Finkelstein SE, Fernandez E. Stereotactic body radiation therapy for prostate cancer: Rational and reasonable.. Practical radiation oncology, 2014.
  221. Teckie S, McCloskey SA, Steinberg ML. Value: a framework for radiation oncology.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014.
  222. Mohideen N, Kavanagh BD, Beyer D, Madhani S, Steinberg ML. Radiation oncology: a perspective on health reform and value-based initiatives.. Journal of oncology practice, 2014.
  223. Steinberg ML. Protons and The hospital that ate Chicago.. International journal of radiation oncology, biology, physics, 2014.
  224. Dong P, Nguyen D, Ruan D, King C, Long T, Romeijn E, Low DA, Kupelian P, Steinberg M, Yang Y, Sheng K. Feasibility of prostate robotic radiation therapy on conventional C-arm linacs.. Practical radiation oncology, 2013.
  225. Wallner PE, Anscher MS, Barker CA, Bassetti M, Bristow RG, Cha YI, Dicker AP, Formenti SC, Graves EE, Hahn SM, Hei TK, Kimmelman AC, Kirsch DG, Kozak KR, Lawrence TS, Marples B, McBride WH, Mikkelsen RB, Park CC, Weidhaas JB, Zietman AL, Steinberg M. Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary.. International journal of radiation oncology, biology, physics, 2013.
  226. Park SJ, Chung M, Demanes DJ, Banerjee R, Steinberg M, Kamrava M. Dosimetric comparison of 3-dimensional planning techniques using an intravaginal multichannel balloon applicator for high-dose-rate gynecologic brachytherapy.. International journal of radiation oncology, biology, physics, 2013.
  227. King CR, Collins S, Fuller D, Wang PC, Kupelian P, Steinberg M, Katz A. Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials.. International journal of radiation oncology, biology, physics, 2013.
  228. Kamrava M, Rwigema JC, Chung M, Banerjee R, Wang J, Steinberg M, Demanes DJ. Predictors of distant metastasis after combined HDR brachytherapy and external beam radiation for prostate cancer.. Journal of contemporary brachytherapy, 2013.
  229. Mehta N, Selch M, Wang PC, Federman N, Lee JM, Eilber FC, Chmielowski B, Agazaryan N, Steinberg M, Lee P. Safety and efficacy of stereotactic body radiation therapy in the treatment of pulmonary metastases from high grade sarcoma.. Sarcoma, 2013.
  230. King CR, Freeman D, Kaplan I, Fuller D, Bolzicco G, Collins S, Meier R, Wang J, Kupelian P, Steinberg M, Katz A. Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2013.
  231. Mehta NH, Kamrava M, Wang PC, Steinberg M, Demanes J. Prostate-specific antigen bounce after high-dose-rate monotherapy for prostate cancer.. International journal of radiation oncology, biology, physics, 2013.
  232. Steinberg M, McBride WH, Vlashi E, Pajonk F. National Institutes of Health funding in radiation oncology: a snapshot.. International journal of radiation oncology, biology, physics, 2013.
  233. Qi XS, Hu AY, Lee SP, Lee P, DeMarco J, Li XA, Steinberg ML, Kupelian P, Low D. Assessment of interfraction patient setup for head-and-neck cancer intensity modulated radiation therapy using multiple computed tomography-based image guidance.. International journal of radiation oncology, biology, physics, 2013.
  234. Lee P, Eppinga W, Lagerwaard F, Cloughesy T, Slotman B, Nghiemphu PL, Wang PC, Kupelian P, Agazaryan N, Demarco J, Selch MT, Steinberg M, Kang JJ. Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis.. International journal of radiation oncology, biology, physics, 2013.
  235. Kamrava M, Chung MP, Kayode O, Wang J, Marks L, Kupelian P, Steinberg M, Park SJ, Demanes DJ. Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatment.. Brachytherapy, 2013.
  236. Kamrava M, Chung MP, Demarco J, Kayode O, Park SJ, Borja L, Chow L, Lee SP, Steinberg ML, Demanes DJ. Electronic brachytherapy for postsurgical adjuvant vaginal cuff irradiation therapy in endometrial and cervical cancer: a retrospective study.. Brachytherapy, 2012.
  237. White EC, Kamrava MR, Demarco J, Park SJ, Wang PC, Kayode O, Steinberg ML, Demanes DJ. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry.. International journal of radiation oncology, biology, physics, 2012.
  238. Raghavan D, Steinberg M, Sandler H. Neutron radiotherapy in South Africa: neutron radiotherapy: Abratt supported.. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2012.
  239. Demanes DJ, Friedman JM, Park SJ, Steinberg ML, Hayes JK, Kamrava MR. Brachytherapy catheter spacing and stabilization technique.. Brachytherapy, 2012.
  240. Armin BB, Hokugo A, Nishimura I, Tamplen M, Beumer J, Steinberg ML, Abemayor E, Nabili V. Brachytherapy-mediated bone damage in a rat model investigating maxillary osteoradionecrosis.. Archives of otolaryngology--head & neck surgery, 2012.
  241. Mehta N, King CR, Agazaryan N, Steinberg M, Hua A, Lee P. Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control.. Practical radiation oncology, 2011.
  242. Zumsteg Z, DeMarco J, Lee SP, Steinberg ML, Lin CS, McBride W, Lin K, Wang PC, Kupelian P, Lee P. Image guidance during head-and-neck cancer radiation therapy: analysis of alignment trends with in-room cone-beam computed tomography scans.. International journal of radiation oncology, biology, physics, 2011.
  243. Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, Khayat D, Boyle P, Autier P, Tannock IF, Fojo T, Siderov J, Williamson S, Camporesi S, McVie JG, Purushotham AD, Naredi P, Eggermont A, Brennan MF, Steinberg ML, De Ridder M, McCloskey SA, Verellen D, Roberts T, Storme G, Hicks RJ, Ell PJ, Hirsch BR, Carbone DP, Schulman KA, Catchpole P, Taylor D, Geissler J, Brinker NG, Meltzer D, Kerr D, Aapro M. Delivering affordable cancer care in high-income countries.. The Lancet. Oncology, 2011.
  244. Tamplen M, Trapp K, Nishimura I, Armin B, Steinberg M, Beumer J, Abemayor E, Nabili V. Standardized analysis of mandibular osteoradionecrosis in a rat model.. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2011.
  245. Wallner PE, Steinberg ML, Konski AA. Controversies in the adoption of new healthcare technologies.. Frontiers of radiation therapy and oncology, 2011.
  246. Steinberg M. The overthrow of the (evidence) hierarchy.. Practical radiation oncology, 2011.
  247. Wallner PE, Steinberg ML, Larson D. [Not Available].. Practical radiation oncology, 2011.
  248. Grant JD, Litwin MS, Kwan L, Lee SP, Steinberg ML, King CR. Does hormone therapy exacerbate the adverse effects of radiotherapy in men with prostate cancer? A quality of life study.. The Journal of urology, 2011.
  249. McCloskey SA, Lee SP, Steinberg ML. Roles and types of radiation in breast cancer treatment: early breast cancer, locoregionally advanced, and metastatic disease.. Current opinion in obstetrics & gynecology, 2011.
  250. Shaughnessy P, Islas-Ohlmayer M, Murphy J, Hougham M, MacPherson J, Winkler K, Silva M, Steinberg M, Matous J, Selvey S, Maris M, McSweeney PA. Cost and clinical analysis of autologous hematopoietic stem cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamide.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010.
  251. Cohen M, Nishimura I, Tamplen M, Hokugo A, Beumer J, Steinberg ML, Suh JD, Abemayor E, Nabili V. Animal model of radiogenic bone damage to study mandibular osteoradionecrosis.. American journal of otolaryngology, 2010.
  252. Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA, American Society for Therapeutic Radiology and Oncology, American College of Radiology. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy.. International journal of radiation oncology, biology, physics, 2010.
  253. Lin K, Lee SP, Steinberg ML. Selection bias clouds apparent benefit of longer hormone duration.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009.
  254. Steinberg ML, Konski A. Proton beam therapy and the convoluted pathway to incorporating emerging technology into routine medical care in the United States.. Cancer journal (Sudbury, Mass.), 2009.
  255. Steinberg M. Degarelix: a gonadotropin-releasing hormone antagonist for the management of prostate cancer.. Clinical therapeutics, 2009.
  256. Steinberg M. Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer.. Clinical therapeutics, 2008.
  257. Steinberg ML. Inequity in cancer care: explanations and solutions for disparity.. Seminars in radiation oncology, 2008.
  258. Steinberg ML. Introduction: health policy and health care economics observed.. Seminars in radiation oncology, 2008.
  259. D'Ambrosio DJ, Pollack A, Harris EE, Price RA, Verhey LJ, Roach M, Demanes DJ, Steinberg ML, Potters L, Wallner PE, Konski A. Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer.. International journal of radiation oncology, biology, physics, 2008.
  260. Steinberg ML, Fremont A, Khan DC, Huang D, Knapp H, Karaman D, Forge N, Andre K, Chaiken LM, Streeter OE. Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges.. Cancer, 2006.
  261. Potters L, Steinberg M, Rose C, Timmerman R, Ryu S, Hevezi JM, Welsh J, Mehta M, Larson DA, Janjan NA, American Society for Therapeutic Radiology and Oncology, American College of Radiology. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy.. International journal of radiation oncology, biology, physics, 2004.
  262. Foulds J, Burke M, Steinberg M, Williams JM, Ziedonis DM. Advances in pharmacotherapy for tobacco dependence.. Expert opinion on emerging drugs, 2004.
  263. Potters L, Steinberg M, Wallner P, Hevezi J. How one defines intensity-modulated radiation therapy.. International journal of radiation oncology, biology, physics, 2003.
  264. Spencer BA, Steinberg M, Malin J, Adams J, Litwin MS. Quality-of-care indicators for early-stage prostate cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003.